These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 28413163)

  • 1. ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance.
    Haller JF; Mintah IJ; Shihanian LM; Stevis P; Buckler D; Alexa-Braun CA; Kleiner S; Banfi S; Cohen JC; Hobbs HH; Yancopoulos GD; Murphy AJ; Gusarova V; Gromada J
    J Lipid Res; 2017 Jun; 58(6):1166-1173. PubMed ID: 28413163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase.
    Chi X; Britt EC; Shows HW; Hjelmaas AJ; Shetty SK; Cushing EM; Li W; Dou A; Zhang R; Davies BSJ
    Mol Metab; 2017 Oct; 6(10):1137-1149. PubMed ID: 29031715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Mimicry Analysis Reveals the Specific Lipases Targeted by the ANGPTL3-ANGPTL8 Complex and ANGPTL4.
    Landfors F; Chorell E; Kersten S
    J Lipid Res; 2023 Jan; 64(1):100313. PubMed ID: 36372100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif.
    Balasubramaniam D; Schroeder O; Russell AM; Fitchett JR; Austin AK; Beyer TP; Chen YQ; Day JW; Ehsani M; Heng AR; Zhen EY; Davies J; Glaesner W; Jones BE; Siegel RW; Qian YW; Konrad RJ
    J Lipid Res; 2022 May; 63(5):100198. PubMed ID: 35307397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ApoA5 lowers triglyceride levels via suppression of ANGPTL3/8-mediated LPL inhibition.
    Chen YQ; Pottanat TG; Zhen EY; Siegel RW; Ehsani M; Qian YW; Konrad RJ
    J Lipid Res; 2021; 62():100068. PubMed ID: 33762177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiopoietin-like protein 4(E40K) and ANGPTL4/8 complex have reduced, temperature-dependent LPL-inhibitory activity compared to ANGPTL4.
    Chen YQ; Pottanat TG; Siegel RW; Ehsani M; Qian YW; Roell WC; Konrad RJ
    Biochem Biophys Res Commun; 2021 Jan; 534():498-503. PubMed ID: 33239171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism.
    Wen Y; Chen YQ; Konrad RJ
    Curr Opin Lipidol; 2024 Apr; 35(2):58-65. PubMed ID: 37962908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiopoietin-like 3 inhibition of endothelial lipase is not modulated by angiopoietin-like 8.
    Sylvers-Davie KL; Segura-Roman A; Salvi AM; Schache KJ; Davies BSJ
    J Lipid Res; 2021; 62():100112. PubMed ID: 34461133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between ANGPTL3, 4, and 8 and lipid and glucose metabolism markers in patients with diabetes.
    Harada M; Yamakawa T; Kashiwagi R; Ohira A; Sugiyama M; Sugiura Y; Kondo Y; Terauchi Y
    PLoS One; 2021; 16(7):e0255147. PubMed ID: 34293055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity.
    Kovrov O; Kristensen KK; Larsson E; Ploug M; Olivecrona G
    J Lipid Res; 2019 Apr; 60(4):783-793. PubMed ID: 30686789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Angiopoietin-Like Protein 3 and 8 Complex Interacts with Lipoprotein Lipase and Induces LPL Cleavage.
    Jin N; Matter WF; Michael LF; Qian Y; Gheyi T; Cano L; Perez C; Lafuente C; Broughton HB; Espada A
    ACS Chem Biol; 2021 Mar; 16(3):457-462. PubMed ID: 33656326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids.
    Chen YQ; Pottanat TG; Siegel RW; Ehsani M; Qian YW; Zhen EY; Regmi A; Roell WC; Guo H; Luo MJ; Gimeno RE; Van't Hooft F; Konrad RJ
    J Lipid Res; 2020 Aug; 61(8):1203-1220. PubMed ID: 32487544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between Serum Angiopoietin-like Proteins 3 and 8 and Atherogenic Lipid Biomarkers in Non-Diabetic Adults Depends on Gender and Obesity.
    Murawska K; Krintus M; Kuligowska-Prusinska M; Szternel L; Stefanska A; Sypniewska G
    Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8.
    Sylvers-Davie KL; Davies BSJ
    Am J Physiol Endocrinol Metab; 2021 Oct; 321(4):E493-E508. PubMed ID: 34338039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Potential of ANGPTL8 Antagonism to Simultaneously Reduce Triglyceride and Increase HDL-Cholesterol Plasma Levels.
    Zhang R
    Front Cardiovasc Med; 2021; 8():795370. PubMed ID: 34869703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL).
    Lee EC; Desai U; Gololobov G; Hong S; Feng X; Yu XC; Gay J; Wilganowski N; Gao C; Du LL; Chen J; Hu Y; Zhao S; Kirkpatrick L; Schneider M; Zambrowicz BP; Landes G; Powell DR; Sonnenburg WK
    J Biol Chem; 2009 May; 284(20):13735-13745. PubMed ID: 19318355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboxyl-terminal sequences in APOA5 are important for suppressing ANGPTL3/8 activity.
    Chen YQ; Yang Y; Zhen EY; Beyer TP; Li H; Wen Y; Ehsani M; Jackson N; Xie K; Jung H; Scheithauer JL; Kumari A; Birrane G; Russell AM; Balasubramaniam D; Liao Z; Siegel RW; Qian Y; Ploug M; Young SG; Konrad RJ
    Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2322332121. PubMed ID: 38625948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical angiopoietin-like protein that regulates ANGPTL3.
    Quagliarini F; Wang Y; Kozlitina J; Grishin NV; Hyde R; Boerwinkle E; Valenzuela DM; Murphy AJ; Cohen JC; Hobbs HH
    Proc Natl Acad Sci U S A; 2012 Nov; 109(48):19751-6. PubMed ID: 23150577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A highly conserved motif within the NH2-terminal coiled-coil domain of angiopoietin-like protein 4 confers its inhibitory effects on lipoprotein lipase by disrupting the enzyme dimerization.
    Yau MH; Wang Y; Lam KS; Zhang J; Wu D; Xu A
    J Biol Chem; 2009 May; 284(18):11942-52. PubMed ID: 19246456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking.
    Zhang R
    Open Biol; 2016 Apr; 6(4):150272. PubMed ID: 27053679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.